{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:31:34Z","timestamp":1790893894345,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.det.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T18:18:44Z","timestamp":1448561924000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Inflammatory Mechanisms in Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"34","author":[{"given":"G.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol P.","family":"Prens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.det.2015.08.004_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D35VW402NF","article-title":"Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2015.08.004_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2015.08.004_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib5","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.12550","article-title":"Hidradenitis suppurativa: the role of immune dysregulation","volume":"53","author":"Kelly","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O'Shea","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A\u00a0double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","article-title":"Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa","volume":"166","author":"Emelianov","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2340\/00015555-1492","article-title":"Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa","volume":"93","author":"Mozeika","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2015.08.004_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity","volume":"148","author":"Dr\u00e9no","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2015.08.004_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-alpha) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex\u00a0vivo study","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib18","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A\u00a0crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.det.2015.08.004_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.det.2015.08.004_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.det.2015.08.004_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellimm.2015.01.011","article-title":"Dermal \u03b3\u03b4 T cells - What have we learned?","volume":"296","author":"O'Brien","year":"2015","journal-title":"Cell Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift?","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2011.07.020","article-title":"Expression of innate defense antimicrobial peptides in hidradenitis suppurativa","volume":"66","author":"Hofmann","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaad.2008.12.033","article-title":"Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa","volume":"61","author":"Schlapbach","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","article-title":"Innate immunity: the virtues of a nonclonal system of recognition","volume":"91","author":"Medzhitov","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.det.2015.08.004_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.det.2015.08.004_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2007.08425.x","article-title":"Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor","volume":"158","author":"Hunger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","article-title":"Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment","volume":"166","author":"Sartorius","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1999.02613.x","article-title":"Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery","volume":"140","author":"Lapins","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib32","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis suppurativa, France","volume":"20","author":"Guet-Revillet","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.det.2015.08.004_bib33","doi-asserted-by":"crossref","DOI":"10.5070\/D3212025709","article-title":"Extensive hidradenitis suppurativa (HS) Hurly stage III disease treated with intravenous (IV) linezolid and meropenem with rapid remission","volume":"21","author":"Scheinfeld","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2015.08.004_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","article-title":"Considering hidradenitis suppurativa as a bacterial biofilm disease","volume":"652","author":"Kathju","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.det.2015.08.004_bib35","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.det.2015.08.004_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjd.12068","article-title":"Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of acne inversa","volume":"168","author":"Melnik","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.1103102","article-title":"Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli","volume":"189","author":"Gentle","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0278-6915(00)00051-X","article-title":"The relative toxicity of compounds in mainstream cigarette smoke condensate","volume":"38","author":"Smith","year":"2000","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.det.2015.08.004_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.it.2009.06.005","article-title":"The aryl hydrocarbon receptor in immunity","volume":"30","author":"Esser","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib43","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","article-title":"Functional significance of non-neuronal acetylcholine in skin epithelia","volume":"80","author":"Hana","year":"2007","journal-title":"Life Sci"},{"issue":"193","key":"10.1016\/j.det.2015.08.004_bib44","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.4049\/jimmunol.1302412","article-title":"Cigarette smoke primes the pulmonary environment to IL-1\u03b1\/CXCR-2-dependent nontypeable Haemophilus influenzae-exacerbated neutrophilia in mice","volume":"15","author":"Nikota","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.det.2015.08.004_bib45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1099\/0022-1317-49-7-675","article-title":"Antimicrobial activity of nicotine against a spectrum of bacterial and fungal pathogens","volume":"49","author":"Pavia","year":"2000","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.det.2015.08.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12971-014-0026-3","article-title":"Scratching the surface - tobacco-induced bacterial biofilms","volume":"13","author":"Hutcherson","year":"2015","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.det.2015.08.004_bib47","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.12233","article-title":"Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support","volume":"168","author":"Danby","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00403-011-1169-1","article-title":"Innate immunity in the pathogenesis of psoriasis","volume":"303","author":"Sweeney","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2015.08.004_bib49","unstructured":"Miller IM, Holzman RJ, Hamzavi I. Prevalence, risk factors, and co-morbidities of HS. Derm Clin, in press."},{"key":"10.1016\/j.det.2015.08.004_bib50","first-page":"250","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.det.2015.08.004_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib52","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.det.2015.08.004_bib53","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2013.5377","article-title":"Successful treatment of severe hidradenitis suppurativa with anakinra","volume":"149","author":"Zarchi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2015.08.004_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000343221","article-title":"Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report","volume":"226","author":"van der Zee","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2015.08.004_bib56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2015.08.004_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpba.2014.12.020","article-title":"Emerging field of metabolomics: Big promise for cancer biomarker identification and drug discovery","volume":"107C","author":"Patel","year":"2015","journal-title":"J\u00a0Pharm Biomed Anal"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351500100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351500100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T08:25:07Z","timestamp":1653639907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351500100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S073386351500100X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.08.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory Mechanisms in Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}